Clinical observation of Nianmo Decoction in preventing recurrence of non muscle invasive bladder cancer through curcumin mediated immune pathway
- Conditions
- on muscle invasive bladder cancer
- Registration Number
- ITMCTR2000003839
- Lead Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Aged 18 to 85 years old;
2. Non invasive bladder cancer (TA: non-invasive papillary carcinoma; T1: tumor invasion of subepithelial connective tissue) after resection of urethral bladder tumor;
3. According to the syndrome type of traditional Chinese medicine, the diagnosis of Damp heat accumulation;
4. Consent to participate in the trial and sign informed consent.
1. Combined with cardiovascular, liver, kidney and hematopoietic system and other serious diseases;
2. Severe malnutrition and digestive system diseases;
3. Those who participated in or are participating in other clinical trials 3 months ago;
4. There are familial hereditary diseases or other diseases that may affect the test;
5. The researcher assessed that they were not suitable for the study;
6. Other treatment methods that may affect the evaluation of this therapy cannot be stopped.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whether there is tumor recurrence after cystoscopy;
- Secondary Outcome Measures
Name Time Method